iRadimed (IRMD) vs DENTSPLY SIRONA (XRAY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iRadimed (IRMD) has outperformed DENTSPLY SIRONA (XRAY) over the past year, gaining 11.7% versus a loss of 29.8%. Over five years, IRMD leads with a +134.2% price change compared with -85.0% for XRAY. DENTSPLY SIRONA is the larger company by market cap ($1.73 billion vs $1.10 billion), about 1.6 times the size.
On valuation, DENTSPLY SIRONA trades at a lower forward P/E (5.8x vs 35.0x for iRadimed). DENTSPLY SIRONA offers the higher dividend yield (3.68% vs 0.90%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRMD | XRAY |
|---|---|---|
| Share price | $85.88 | $8.69 |
| Market cap | $1.10B | $1.73B |
| 1-day change | +0.48% | +1.76% |
| YTD return | -11.72% | -23.97% |
| 1-year return | +11.72% | -29.81% |
| 5-year return | +134.20% | -84.98% |
| P/E ratio (TTM) | 47.98 | — |
| Forward P/E | 35.01 | 5.81 |
| EPS (TTM) | $1.79 | $-2.73 |
| Dividend yield | 0.90% | 3.68% |
| Annual dividend | $0.77 | $0.32 |
| Revenue (latest FY) | — | $3.68B |
| Revenue growth (YoY) | — | -2.98% |
| Net income (latest FY) | — | $-598.00M |
| Gross margin | — | 50.00% |
| Operating margin | — | -11.47% |
| Net margin | — | -16.25% |
| 52-week high | $107.90 | $14.76 |
| 52-week low | $71.34 | $8.38 |
| Distance from 52-week high | -20.41% | -41.12% |
| Analyst consensus | none | hold |
| Avg. price target upside | +37.40% | +54.20% |
| Average volume | 125.83K | 4.76M |
| Shares outstanding | 12.79M | 199.35M |
| Employees | 166 | 14,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRMD has outperformed XRAY by 41.5 percentage points over the past year.
- DENTSPLY SIRONA offers a meaningfully higher dividend yield (3.68% vs 0.90%).
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
About DENTSPLY SIRONA
XRAY stock →DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
Health Care · Medical/Dental Instruments · 14,000 employees
IRMD vs XRAY FAQ
Which is bigger, iRadimed or DENTSPLY SIRONA?
DENTSPLY SIRONA (XRAY) is larger, with a market capitalization of $1.73B compared with $1.10B for iRadimed (IRMD).
Which stock has performed better over the past year, IRMD or XRAY?
IRMD returned +11.72% over the past 12 months, compared with -29.81% for XRAY (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, iRadimed or DENTSPLY SIRONA?
DENTSPLY SIRONA has the higher yield at 3.68%, compared with 0.90% for iRadimed.
Are iRadimed and DENTSPLY SIRONA in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.